You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm plans to launch several products based on its proprietary machine learning method for identifying variants that alter cellular biochemistry and cause disease.
The ISCB is currently mulling offering an industry track at ISMB, providing training workshops and internships for students, and more.
The method uses a probabilistic approach to mine drug structure, side effects, and genomic and clinical data to identify new drug targets and mechanisms of action.
SQream's first product for the space is based on its database technology and provides tools for storing and analyzing genomic sequence data.
Eisai will use Genomics' tools in its drug R&D efforts including for target selection, validation, and more.
The course sequence is intended to teach basic computational and statistical skills for analyzing and exploring high-throughput sequencing data.
At Brigham and Women's Hospital, Kimberly Glass is integrating different types of omics data to develop useful gene models.
The New York Times profiles Jeffrey Hammerbacher, who has moved from Bear Stearns and Facebook to the Icahn School of Medicine at Mount Sinai.
The partnership marries Foundation's genomic knowledgebase with H3's drug discovery engine and computational biology platform.
A University of Washington-led team looked at strain diversity in human gut microbiomes using a newly developed computational pipeline.
Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.
Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.
Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.